Emo Capital Corp. (NUVI)

[adijas]

More important, Glass sold the shell: On September 23, 2020, Mr. Glass sold 58,000,000 million shares of common stock, representing approximately 96.67% of the shares he owned in the Company, and equal to approximately 60.73% of the total number of outstanding shares of the Company’s common stock, to Collingswood Capital Group


New CEO Adeeb Tadros became a director and the president of the Company on September 23, 2020. Prior to joining the Company, Mr. Tadros served as a Director of Farmosa Global, Inc. from March 2020 to October 2020 and as the managing director Scottsan International from February 2012 to March 2020. Both companies are a global professional services firms that develop and implement strategic plans and compliant corporate policies, maintain efficient communications protocols with customers and stakeholders and provide operations analysis and efficiency implementations. From June 2003 to January 2004, Mr. Tadros was employed as a Laboratory Research Consultant at the Mayo Clinic Endocrinology Laboratory in Chicago, Illinois, where he developed a new analysis test for 18-Hidroxicortisol. Mr. Tadros holds an M.D. from the American University of Antigua Medical School and a B.S. in Chemistry and Biology from the DePaul University. Mr. Tadros is fluent in English, Spanish and Arabic. The term of office of our director expires at the Company’s annual meeting of stockholders or until his successor is duly elected and qualified. Directors are not compensated for serving as such. Officers serve at the discretion of the board of directors.